Clinical Trial Update: Prevention of Cisplatin-induced Nephrotoxicity [Phase 2, Phase 3]

View source ↗

Summary

A Mahidol University trial aims to prevent cisplatin-induced nephrotoxicity with Phase 2 and Phase 3 studies that are not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Renal Tubulopathy

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Mahidol University | Conditions: Acute Kidney Injury, Renal Tubulopathy | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING